Aoife Campbell

Aoife Campbell has a diverse work experience in the field of pharmaceuticals and research. Aoife currently holds the position of Drug Discovery Translational Scientist at Turbine, starting from February 2023. Prior to this, they worked as a Pharmacologist at Healx from May 2022 to December 2022. Aoife also served as a Postdoctoral Researcher at the MRC Laboratory of Molecular Biology (LMB) from January 2021 to April 2022. Before that, Aoife pursued their PhD at the Royal College of Surgeons in Ireland, focusing on microRNAs as targets for neurodevelopmental disorders and pediatric epilepsy, from October 2016 to July 2020. Aoife gained research experience as a Research Assistant at the Department of Anatomy, Trinity College Dublin from November 2015 to August 2016. Additionally, they completed their Master's degree at the National University of Ireland, Galway, where their research project centered around fear-conditioned analgesia and the levels of endocannabinoids in different rat models.

Aoife Campbell's education history includes obtaining a Master's degree in Neuropharmacology from the University of Galway from 2014 to 2015. Aoife then went on to attend the Royal College of Surgeons in Ireland (RCSI) from 2016 to 2020, although the degree name and field of study are not specified. Additionally, they have an unspecified certification in Laboratory Animal Science Training. No further details are provided regarding the institution or the year of obtaining this certification.